Hybridoma tumor cell lines and their monoclonal antibodies...

Details Hybridoma tumor cell lines and their monoclonal antibodies... Hybridoma tumor cell lines and their monoclonal antibodies...

C - Chemistry, Metallurgy

12

N

167/44, 195/1.11

C12N 5/16 (2006.01) C07K 14/43 (2006.01) C07K 16/16 (2006.01) C12P 21/08 (2006.01) G01N 33/566 (2006.01)

Patent

CA 1297819

"HYBRIDOMA TUMOR CELL LINES AND THEIR MONOCLONAL ANTIBODIES TO THAUMATIN" ABSTRACT Disclosed are murine-derived hybridoma tumor cell lines and monoclonal anti-thaumatin antibody substances produced by these cell lines. The monoclonal antibody substances may be used alone or in combination in immunological procedures for isolation of thaumatin and for quantitative detection of thaumatin in fluid samples.

521400

Affiliated with

Also associated with

Rating

Hybridoma tumor cell lines and their monoclonal antibodies... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Hybridoma tumor cell lines and their monoclonal antibodies..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hybridoma tumor cell lines and their monoclonal antibodies... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1298850